CPHRF (Cipher Pharmaceuticals) Cyclically Adjusted Book per Share: $2.17 (As of Mar. 2026)


CPHRF Cipher Pharmaceuticals Inc CPHRF
96 GF Score
Price $11.77
GF Value $12.21
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Cipher Pharmaceuticals Cyclically Adjusted Book per Share?

Cipher Pharmaceuticals CPHRF +1.60% 96 Cyclically Adjusted Book per Share is $2.17 as of Mar. 2026. GuruFocus rates CPHRF with a GF Score™ of 96/100 and a GF Value™ of $12.21 (Fairly Valued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Cipher Pharmaceuticals's adjusted book value per share for the three months ended in Mar. 2026 was $5.228. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $2.17 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Cipher Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was 13.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 14.70% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 15.70% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 11.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Cipher Pharmaceuticals was 16.80% per year. The lowest was 5.50% per year. And the median was 9.95% per year.

As of today (2026-07-01), Cipher Pharmaceuticals's current stock price is $11.765. Cipher Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $2.17. Cipher Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 5.42.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Cipher Pharmaceuticals was 7.78. The lowest was 0.32. And the median was 2.18.


Cipher Pharmaceuticals  (OTCPK:CPHRF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Cipher Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=11.765/2.17
=5.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Cipher Pharmaceuticals was 7.78. The lowest was 0.32. And the median was 2.18.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Cipher Pharmaceuticals Cyclically Adjusted Book per Share Related Terms


Cipher Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Cipher Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cipher Pharmaceuticals Cyclically Adjusted Book per Share Chart

Cipher Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.29 1.40 1.71 1.78 2.11

Cipher Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.85 2.01 2.03 2.11 2.17

CPHRF vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cipher Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cipher Pharmaceuticals Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cipher Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Cipher Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


CPHRF
96GF Score
Cipher Pharmaceuticals Inc CPHRF
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cipher Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cipher Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=5.228/132.2623*132.2623
=5.228

Current CPI (Mar. 2026) = 132.2623.

Cipher Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201606 1.913 102.002 2.481
201609 1.118 101.765 1.453
201612 0.703 101.449 0.917
201703 0.574 102.634 0.740
201706 0.607 103.029 0.779
201709 0.713 103.345 0.913
201712 0.872 103.345 1.116
201803 0.841 105.004 1.059
201806 0.922 105.557 1.155
201809 0.956 105.636 1.197
201812 0.923 105.399 1.158
201903 0.953 106.979 1.178
201906 1.006 107.690 1.236
201909 0.922 107.611 1.133
201912 1.038 107.769 1.274
202003 1.136 107.927 1.392
202006 1.153 108.401 1.407
202009 1.214 108.164 1.484
202012 1.210 108.559 1.474
202103 1.261 110.298 1.512
202106 1.369 111.720 1.621
202109 1.397 112.905 1.637
202112 1.500 113.774 1.744
202203 1.578 117.646 1.774
202206 1.663 120.806 1.821
202209 1.771 120.648 1.941
202212 2.557 120.964 2.796
202303 2.650 122.702 2.856
202306 2.777 124.203 2.957
202309 3.064 125.230 3.236
202312 3.357 125.072 3.550
202403 3.551 126.258 3.720
202406 3.682 127.522 3.819
202409 3.863 127.285 4.014
202412 3.998 127.364 4.152
202503 4.107 129.181 4.205
202506 4.310 129.892 4.389
202509 4.491 130.287 4.559
202512 4.994 130.366 5.067
202603 5.228 132.262 5.228

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $2.17 mean?
Cipher Pharmaceuticals (CPHRF) has a Cyclically Adjusted Book per Share of $2.17 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Cipher Pharmaceuticals and its competitors.
Is Cipher Pharmaceuticals' Cyclically Adjusted Book per Share too high?
Cipher Pharmaceuticals' current Cyclically Adjusted Book per Share is $2.17. Overall, Cipher Pharmaceuticals has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cipher Pharmaceuticals' Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Cipher Pharmaceuticals' Cyclically Adjusted Book per Share of $2.17 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Cipher Pharmaceuticals and its competitors. Cipher Pharmaceuticals's current Cyclically Adjusted Book per Share is $2.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cipher Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Cipher Pharmaceuticals (CPHRF) is currently considered Fairly Valued. The stock's GF Value™ is $12.21, compared to a current price of $11.77 — trading 3.6% below its estimated fair value. The current Cyclically Adjusted Book per Share is $2.17. Cipher Pharmaceuticals' overall GF Score™ is 96/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Cipher Pharmaceuticals (CPHRF), the current Cyclically Adjusted Book per Share is $2.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cipher Pharmaceuticals (CPHRF) Overvalued in 2026?

Based on GuruFocus' analysis, Cipher Pharmaceuticals stock appears to be undervalued. The current stock price of $11.77 is trading 3.6% below its estimated GF Value™ of $12.21. GuruFocus considers Cipher Pharmaceuticals to be Fairly Valued.

Key valuation signals for CPHRF:

  • Cyclically Adjusted Book per Share: $2.17
  • GF Value™: $12.21 vs. price of $11.77 (3.6% below fair value)
  • GF Score™: 96/100 with 5 warning signs

No single metric tells the full story. See the CPHRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cipher Pharmaceuticals Business Description

Other Exchanges PHE:GermanyCPH:Canada
Address 5750 Explorer Drive, Suite 404, Mississauga, ON, CAN, L4W 0A9
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company is building its business through product acquisitions, out-licensing, and in-licensing arrangements. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products, among others. The company's geographical operational areas include Canada and the United States.
96GF Score

Get the complete analysis for CPHRF

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.77
Price
$12.21
GF Value